Get the Stockscreener App
15.61
6.34%
0.93
Biohaven Ltd stock is traded at $15.61, with a volume of 5.70M.
It is up +6.34% in the last 24 hours and up +16.23% over the past month.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
See More
Previous Close:
$14.68
Open:
$16.01
24h Volume:
5.70M
Relative Volume:
2.86
Market Cap:
$1.65B
Revenue:
-
Net Income/Loss:
$-766.97M
P/E Ratio:
-2.0379
EPS:
-7.66
Net Cash Flow:
$-646.43M
1W Performance:
-0.64%
1M Performance:
+16.23%
6M Performance:
-57.71%
1Y Performance:
-60.94%
1-Day Range:
$15.22
$16.12
1-Week Range:
$14.23
$16.14
52-Week Range:
$12.79
$55.70
Biohaven Ltd Stock (BHVN) Company Profile
Name
Biohaven Ltd
Sector
Industry
Phone
203-404-0410
Address
215 CHURCH STREET, NEW HAVEN, CT
Compare BHVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
15.61 | 1.69B | 0 | -766.97M | -646.43M | -7.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-19-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Sep-16-24 | Initiated | Jefferies | Buy |
| Sep-04-24 | Initiated | Bernstein | Outperform |
| Jul-24-24 | Initiated | Morgan Stanley | Overweight |
| Feb-16-24 | Initiated | RBC Capital Mkts | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Dec-22-23 | Initiated | H.C. Wainwright | Buy |
| Dec-08-23 | Initiated | Robert W. Baird | Outperform |
| Jan-24-23 | Initiated | SVB Securities | Outperform |
| Jan-04-23 | Initiated | JP Morgan | Overweight |
| Dec-02-22 | Initiated | BTIG Research | Buy |
| Oct-26-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-12-22 | Initiated | Piper Sandler | Overweight |
| Aug-19-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-08-22 | Downgrade | Wedbush | Outperform → Neutral |
| May-11-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Oct-19-21 | Resumed | Morgan Stanley | Equal-Weight |
| Aug-10-21 | Downgrade | UBS | Buy → Neutral |
| Aug-03-21 | Reiterated | Canaccord Genuity | Buy |
| Mar-11-21 | Initiated | UBS | Buy |
| Dec-15-20 | Initiated | H.C. Wainwright | Buy |
| Apr-17-20 | Initiated | Cowen | Outperform |
| Feb-10-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-06-20 | Initiated | Mizuho | Buy |
| Nov-22-19 | Initiated | Wedbush | Outperform |
| Jun-25-19 | Reiterated | Canaccord Genuity | Buy |
| May-06-19 | Initiated | Goldman | Buy |
| Apr-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-04-19 | Reiterated | Needham | Buy |
| Jul-03-18 | Reiterated | Needham | Buy |
| Jul-02-18 | Reiterated | Needham | Buy |
| Apr-05-18 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-22-18 | Reiterated | Canaccord Genuity | Buy |
| Dec-15-17 | Initiated | Canaccord Genuity | Buy |
| Oct-03-17 | Reiterated | Needham | Buy |
View All
Biohaven Ltd Stock (BHVN) Latest News
Biohaven Ltd. Stockholders are Urged to Seek Representation to Lead the BHVN Class Action: Contact Robbins LLP for More Information - PR Newswire
Deadline Alert: Biohaven Ltd. (BHVN) Investors Who Lost - GlobeNewswire
RBC says PTC Therapeutics CRL may signal difficulty for Biohaven - Yahoo Finance
BHVN Investors Have the Opportunity to Lead the Biohaven Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire
Should you wait for a breakout in Biohaven Ltd.Weekly Profit Summary & Weekly High Conviction Trade Ideas - Newser
Using Python tools to backtest Biohaven Ltd. strategies2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Biohaven Ltd. stock retracement – recovery analysis2025 Analyst Calls & Technical Confirmation Trade Alerts - Newser
Is this a good reentry point in Biohaven Ltd.July 2025 Summary & Free Safe Entry Trade Signal Reports - Newser
Chart based analysis of Biohaven Ltd. trendsSell Signal & Daily Volume Surge Trade Alerts - Newser
Using fundamentals and technicals on Biohaven Ltd.2025 Macro Impact & AI Enhanced Trading Alerts - Newser
Is now a turning point for Biohaven Ltd.July 2025 Update & Breakout Confirmation Trade Signals - Newser
Levi & Korsinsky Reminds Biohaven Ltd. Investors of the - GlobeNewswire
Can machine learning forecast Biohaven Ltd. recoveryJuly 2025 EndofMonth & Trade Opportunity Analysis Reports - Newser
What to do if you’re stuck in Biohaven Ltd.Short Setup & Weekly Chart Analysis and Guides - Newser
Levi & Korsinsky Moves to SueWallSt for Biohaven Ltd. Investors That Lost Money - ACCESS Newswire
Is Biohaven Ltd. stock reversal real or fakePortfolio Risk Report & Weekly Chart Analysis and Guides - Newser
Biohaven Ltd. (BHVN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Shareholders that lost money on Biohaven Ltd.(BHVN) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - WV News
Biohaven Ltd. (BHVN) Receives a Buy from Bernstein - The Globe and Mail
Biohaven stock price target raised to $60 by BTIG on SCA treatment potential - Investing.com
Biohaven Ltd. Reports Q2 2025 Financial Results - TipRanks
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BHVN - GlobeNewswire Inc.
Leerink Lowers Biohaven (BHVN) PT to $50 Following Q2 Report, Acknowledging Positive Pipeline Progress - MSN
Burned by Biohaven Ltd.? Contact Levi & Korsinsky to SueWallSt and Fight Back - ACCESS Newswire
BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Lost Money on Biohaven Ltd.(BHVN)? Join Class Action Suit Seeking Recovery – Contact The Gross - Bluefield Daily Telegraph
Biohaven Ltd. (BHVN) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 12, 2025 Deadline - ACCESS Newswire
BHVN Stock Update: Biohaven Ltd’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
Shareholders of Biohaven Ltd. (BHVN): Protect Your Rights Before September 12, 2025Contact Levi & Korsinsky - ACCESS Newswire
Lost Money on Biohaven Ltd.(BHVN)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - PR Newswire
US Bancorp DE Grows Stock Holdings in Biohaven Ltd. $BHVN - Defense World
Securities Fraud Class Action Filed Against Biohaven Ltd. (BHVN)Levi & Korsinsky Reminds Investors of September 12, 2025 - ACCESS Newswire
Cantor Fitzgerald Forecasts Stronger Earnings for Biohaven - Defense World
Bragar Eagel & Squire, P.C. Urges Investors in XPLR - GlobeNewswire
Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits - Morningstar
Pomerantz Law Firm Announces the Filing of a Class Action Against Biohaven Ltd. and Certain OfficersBHVN - PR Newswire
Will earnings trigger a reversal in Biohaven Ltd.Quarterly Trade Review & Real-Time Volume Surge Alerts - Newser
Biohaven's Share Resale and Knopp Amendment: Implications for Liquidity and Governance Risk - AInvest
Join Class Action to Recover Losses from Biohaven Ltd. (BHVN)Contact Levi & Korsinsky Before September 12, 2025 - ACCESS Newswire
Biohaven files prospectus for resale of 3.6 million shares tied to Knopp deal - Investing.com
Biohaven Ltd. Files Prospectus for Share Resale - TipRanks
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Biohaven - GlobeNewswire
Will Biohaven Ltd. stock go up soonMarket Risk Report & Free Reliable Trade Execution Plans - Newser
Can Biohaven Ltd. reach all time highs this yearWeekly Profit Analysis & Growth Oriented Trading Recommendations - thegnnews.com
Lost Money on Biohaven Ltd. (BHVN)? Contact Levi & Korsinsky to Join Class Action Before September 12, 2025 - ACCESS Newswire
Faruqi & Faruqi Reminds Biohaven Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 12, 2025BHVN - The Malaysian Reserve
Class Action Filed Against Biohaven Ltd. (BHVN) Seeking Recovery for InvestorsContact Levi & Korsinsky - Morningstar
Levi & Korsinsky Urges Biohaven Ltd. (BHVN) Shareholders to Act Before Lead Plaintiff Deadline September 12, 2025 - ACCESS Newswire
Cantor Fitzgerald Reduces Earnings Estimates for Biohaven - Defense World
Top Risks to Consider Before Buying Biohaven Ltd. StockJuly 2025 Trends & Weekly Return Optimization Alerts - Newser
Biohaven Ltd.: Strategic Shift and Upcoming Milestones Justify Buy Rating Despite Setbacks - TipRanks
Biohaven Ltd Stock (BHVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):